Research Hub

Preclinical
Global searchLocal Demo

Preclinical

Hide

Program-level preclinical execution view with tox signals, cohort readiness, and translational handoff metrics. Business and scientific purpose: de-risk progression to translational milestones with stronger efficacy, safety, and biomarker evidence. Preclinical is connected to linked entities, metrics, and workflow actions in this workspace. Use these panels to review evidence, identify risks, and decide the next best scientific action. The view uses deterministic demo data shaped to mirror realistic drug discovery operations.

Preclinical Health Snapshot

Tox risk high
669
Animal approvals open
20
Biomarker-linked studies
30
PK/PD-ready assets
24

Priority Programs

idnamestagetargetArea
PRG-001ATLAS-100Lead OptimisationEGFR
PRG-002KCL-101DiscoveryTau
PRG-003KCL-102PreclinicalKRAS
PRG-004NOVA-103PreclinicalKRAS
PRG-005ATLAS-104PreclinicalTau
PRG-006KCL-105PreclinicalEGFR
PRG-007ATLAS-106DiscoveryEGFR
PRG-008KCL-107DiscoveryEGFR
PRG-009NOVA-108DiscoveryKRAS
PRG-010NOVA-109Lead OptimisationEGFR
PRG-011KCL-110PreclinicalKRAS
PRG-012NOVA-111DiscoveryEGFR
PRG-013KCL-112DiscoveryEGFR
PRG-014ATLAS-113DiscoveryKRAS
PRG-015ATLAS-114Lead OptimisationKRAS
PRG-016KCL-115PreclinicalTau
PRG-017NOVA-116Lead OptimisationPD-1
PRG-018NOVA-117PreclinicalIL-6
PRG-019NOVA-118DiscoveryKRAS
PRG-020ATLAS-119Lead OptimisationPD-1